In 2023, the medical device market was worth approximately *** billion U.S. dollars in the United States. Throughout the time interval, the revenue in the medical device market increased year-on-year, except for the pandemic-affected 2020.

Major companies have continued to dominate medical device manufacturing, making strategic acquisitions and heavily investing in research and development (R&D) to boost market share. Industry giants like Johnson & Johnson and Boston Scientific have actively pursued acquisitions to expand their portfolios and strengthen their market positions. Johnson & Johnson's 2022 acquisition of Abiomed fortified its place in treating cardiovascular diseases, and Boston Scientific's 2023 acquisition of Axionics expanded its urology product offerings. At the same time, high demand for healthcare from the aging population has made room for an influx of start-ups. Revenue has been climbing at a CAGR of 1.2% to an estimated $56.4 billion over the five years through 2025, including an expected lift of 3.1% in 2024 alone. Innovation has remained a pivotal element in securing growth for medical device manufacturers. Advances in technology and research have led to the development of sophisticated products that can treat rare chronic conditions and ailments. New smart implantable devices, like Biotronik's Dynagen A3 cardiac defibrillator, enhance physicians' ability to treat patients. Government support has been a solid boon for manufacturers, with initiatives like revamped R&D tax credits fuelling innovation. Medical device manufacturers are increasingly focusing on personalizing products and integrating AI, as seen with Medtronic's Genius GI endoscopy tool, allowing them to cater to specific patient needs and improve healthcare outcomes. Since healthcare professionals are under pressure to use the best tools available, the release of new innovative products has directly spurred sales and pushed revenue upward. Buyers' reliance on effective medical devices gives manufacturers significant control over prices, allowing them to maintain solid profit despite swelling R&D budgets. Demographic changes and technological advancements will continue enabling medical device manufacturers to drive revenue growth. As the median age of the U.S. population climbs, demand for orthopedic and neurological devices will surge. Companies will continue investing heavily in R&D to outpace competition in domestic and international markets. Upcoming regulatory changes and potential tariffs under the second Trump administration could present opportunities and challenges, easing regulations but deterring international trade. Despite these hurdles, revenue is set to outpace the previous period's growth, surging at a CAGR of 2.6% to an estimated $64.3 billion through the end of 2030.

The revenue in the 'Medical Devices' segment of the medical technology market in the United States was forecast to continuously increase between 2024 and 2029 by in total **** billion U.S. dollars (+***** percent). After the ninth consecutive increasing year, the revenue is estimated to reach ****** billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the medical technology market in the Dominican Republic and the revenue in the medical technology market in Italy. The Statista Market Insights cover a broad range of additional markets.

The United States medical devices market was valued at USD 197.14 Billion in 2024, driven by rapid technological advancements, strong regulatory support, and a robust innovation ecosystem across the region. It is expected to grow at a CAGR of 6.20% during the forecast period of 2025-2034 and attain a market value of USD 359.77 Billion by 2034. The presence of a well-established FDA approval process is fostering trust and accelerating new product launches.

Demographics also play a role. An aging population with chronic conditions like diabetes, cardiovascular disease, and arthritis is increasing demand for long-term care solutions. Hospitals are upgrading equipment to meet new standards, and outpatient centers are purchasing portable and user-friendly systems to manage costs and improve throughput.

Private sector funding is flowing into innovation hubs in cities like Boston, San Diego, and Minneapolis. These ecosystems combine academic research, clinical trials, and manufacturing in one pipeline, giving U.S.-based developers a speed advantage over global competitors. All this adds up to steady market expansion, particularly in high-margin categories like implantable devices, surgical robotics, and smart diagnostics.

United States Medical Devices Market Size, Share, Growth, Trend & US Medical Devices Market Analysis 2027, By Type, By End User, By Company, By Region, Forecast & Opportunities,

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

Market Size statistics on the Medical Device Manufacturing industry in the US

United States Wearable Medical Devices Market was valued at USD 4.44 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 19.13%.

Pages	85
Market Size	2024: USD 4.44 Billion
Forecast Market Size	2030: USD 12.60 Billion
CAGR	2025-2030: 19.13%
Fastest Growing Segment	Diagnostic Devices
Largest Market	Western Region
Key Players	1. Abbott Laboratories, Inc. 2. Fitbit, Inc. 3. Apple, Inc. 4. GE Healthcare 5. Masimo Corporation 6. Dexcom Inc. 7. Biotelemetry Inc. 8. iRhythm Technologies, Inc. 9. Preventice Solutions, Inc. 10. Medtronic plc

Unlocking the Future: US Medical Devices Market 2027. Discover trends, leading MedTech companies, and industry insights with Ken Research.

The revenue in the 'Medical Devices' segment of the medical technology market in Latin America was forecast to continuously increase between 2024 and 2029 by in total **** billion U.S. dollars (+***** percent). After the ninth consecutive increasing year, the revenue is estimated to reach **** billion U.S. dollars and therefore a new peak in 2029. Find further information concerning the revenue in the 'In Vitro Diagnostics' segment of the medical technology market in Spain and the revenue in the 'Ophthalmic Devices' segment of the medical technology market in Indonesia. The Statista Market Insights cover a broad range of additional markets.

Snapshot img

Medical Devices Market Size 2025-2029

The medical devices market size is forecast to increase by USD 223 billion, at a CAGR of 6.5% between 2024 and 2029. The market is witnessing significant growth, driven by the increasing prevalence of diseases and the emergence of innovative medical technologies. The market is experiencing a surge in demand due to the rising burden of chronic diseases and the growing aging population.

Major Market Trends & Insights

North America dominated the market and accounted for a 37% share in 2023.
The market is expected to grow significantly in Europe region as well over the forecast period.
Based on the End-user, the hospitals and ASCs segment led the market and was valued at USD 430.60 billion of the global revenue in 2023.
Based on the Product Type, the diagnostic devices segment accounted for the largest market revenue share in 2023.

Market Size & Forecast

Market Opportunities: USD 597.90 Billion
Future Opportunities: USD 223 Billion
CAGR (2024-2029): 6.5%
North America: Largest market in 2023

The market continues to evolve, driven by advancements in technology and the growing demand for innovative solutions across various sectors. Cardiovascular device technology, for instance, has seen significant progress with the development of more efficient and effective stents, leading to a 5% annual growth rate. Surgical instrument design has been revolutionized by surgical robotics systems, enabling minimally invasive procedures and improved therapeutic device efficacy. Three-dimensional printed implants are another area of focus, with biomaterial compatibility testing ensuring optimal patient safety and long-term success. Regulatory device compliance remains a critical factor, as mobile health applications and artificial intelligence diagnostics gain popularity.

What will be the Size of the Medical Devices Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

Advanced medical devices, such as implantable devices and diagnostic equipment, are increasingly being adopted to improve patient outcomes and enhance the quality of healthcare. However, the market faces challenges in the form of declining reimbursement and cost containment measures. Healthcare providers and insurers are increasingly focusing on cost savings, leading to pressure on medical device manufacturers to reduce prices. The clinics segment is the second largest segment of the end-user and was valued at USD 104.10 billion in 2023.

Additionally, regulatory compliance and stringent approval processes pose significant challenges to market entrants. Companies must navigate these challenges by developing cost-effective solutions, focusing on regulatory compliance, and collaborating with healthcare providers and insurers to ensure reimbursement for their products. To capitalize on the market opportunities and stay competitive, companies must invest in research and development to bring innovative products to market and collaborate with healthcare providers to address unmet clinical needs.

Neurological device implantation and in-vitro diagnostic testing are also seeing advancements, with precision medicine devices and machine learning algorithms driving diagnostic accuracy. In the realm of diabetes management systems, remote patient monitoring and wearable health trackers are transforming care delivery. Respiratory device performance and drug delivery systems are being optimized for better patient outcomes. Advanced wound care and rehabilitation device technology are also making strides, with connected medical devices and telemedicine platforms facilitating remote care. The market for implantable devices, such as orthopedic implants, is expected to grow at a steady pace, driven by improvements in implantable device design and device cybersecurity standards.

Biomedical device sterilization methods continue to evolve, ensuring patient safety and reducing the risk of infection. A notable example of market dynamism is the integration of health data analytics into clinical trial protocols and patient safety protocols, streamlining research and improving patient care. Overall, the market is characterized by continuous innovation and adaptation to meet the evolving needs of healthcare providers and patients.

How is this Medical Devices Industry segmented?

The medical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Hospitals and ASCs
  Clinics
  Others


Product Type

  Diagnostic devices
  Therapeutic devices
  Monitoring devices
  Assistive and rehabilitation devices
  Others


Application

  Cardiovascul

The antimicrobial-coated medical devices market size is projected to be valued at US$ 1,485.0 million in 2023 and is expected to rise to US$ 5,123.5 million by 2033. The sales of antimicrobial-coated medical devices are expected to register a significant CAGR of 13.2% during the forecast period.

Attribute	Details
Market Estimated Size (2023)	US$ 1,485 million
Market CAGR (2023 to 2033)	13.2%
Devices Market Forecasted Size (2033)	US$ 5,123.5 million

Scope of the Report

Attribute	Details
Growth Rate	CAGR of 13.2% from 2023 to 2033
Base Year of Estimation	2023
Historical Data	2018 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in US$ million and Volume in Units and F-CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis
Key Segments Covered	Device Type Coating Material By Region
Regions Covered	North America Latin America Europe East Asia South Asia The Middle East & Africa Oceania
Key Countries Profiled	The United States Canada Brazil Mexico Germany Italy France The United Kingdom Spain Russia China Japan India GCC Countries Australia
Key Companies Profiled	AST Products Inc. Covalon Technologies Ltd. BASF SE Bio Interaction Ltd. Royal DSM Sciessent LLC Specialty Coating Systems Inc. Hydromer Inc. Dow Chemical Company Biocote PPG Industries, Inc.
Customization & Pricing	Available upon Request

The US Hospital Supplies Market Report is Segmented by Product (Patient Examination Devices, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilization and Disinfectant Equipment, Disposable Hospital Supplies, Syringes and Needles, and Other Types). The Report Offers the Value (USD) for the Above Segments.

The global sales of homecare medical devices are estimated to be worth USD 172.6 billion in 2025 and are anticipated to reach a value of USD 403.4 billion by 2035.

Attributes	Key Insights
Historical Size, 2024	USD 158.5 billion
Estimated Size, 2025	USD 172.6 billion
Projected Size, 2035	USD 403.4 billion
Value-based CAGR (2025 to 2035)	8.9%

Semi Annual Market Update

Particular	Value CAGR
H1	9.6% (2024 to 2034)
H2	9.3% (2024 to 2034)
H1	8.9% (2025 to 2035)
H2	8.4% (2025 to 2035)

Country-wise Insights

Country	Value CAGR (2025 to 2035)
United States	2.3%
Germany	2.0%
Italy	2.5%
UK	4.6%
India	7.3%
China	6.8%

Category-wise Insights

Product	Value Share (2025)
Wheelchairs	57.4%

By Distribution Channel	Value Share (2025)
Online Retailers	39.5%

The medical supplies wholesaling industry is redefined by transformative events, chiefly hospital consolidations and changing healthcare dynamics. Increased mergers and acquisitions have created larger health systems with centralized procurement departments, shifting purchasing power to fewer individuals. This trend aims to enhance efficiencies but poses challenges to wholesalers regarding bulk discounts and demanding nationwide distribution. The competitive landscape sees larger entities benefiting from economies of scale while smaller wholesalers risk being edged out. Technology plays a crucial role in providing an edge over competitors. Wholesalers must increasingly invest in scalable technologies that allow real-time inventory tracking, automated replenishment and strategic partnerships that offer supply chain analytics for cost-saving. A volatile operating environment has decelerated revenue growth, with revenue climbing at a CAGR of 0.4% to an estimated $326.4 billion through the end of 2025, including estimated growth of 4.2% in 2025 alone. The medical supplies wholesaling industry benefits from a surge in healthcare utilization. This is primarily driven by the aging US population and the proliferation of chronic conditions such as obesity and diabetes, demanding increased medical supplies. While posing operational challenges regarding delivery volumes and cost containment, technological advancement, particularly AI, presents the means to navigate these complexities. AI aids in predictive analytics, automated procurement and real-time logistics, boosting efficiencies and mitigating risks. Substantial growth is noted in alternative healthcare delivery systems like telemedicine and home-based care, requiring robust and efficient supply chains from wholesalers to meet the escalating needs. Through the end of 2030, an aging population will persistently fuel growth in the industry. This will strengthen demand for chronic disease management supplies and other age-related medical products. However, the shift towards value-based care productivity will expedite consolidations among wholesalers to effectively cater to demands for cost-efficiency, quality outcomes and coordinated care. This emphasis on value-based care also implies a focus on preventive care, increasing reliance on durable medical equipment suppliers. Continuous innovation in medical devices will offer new paths for wholesalers, including distributing advanced wearables and minimally invasive surgical instruments. Tech advancements will continue to determine the competitiveness of wholesalers with real-time tracking, predictive analytics and AI becoming standard expectations. Strategic investments in these areas will be critical for sustainable success. Revenue will expand at a CAGR of 3.9% to an estimated $395.9 billion over the next five years.

The global medical equipment maintenance market is approximated at a value of US$ 47.8 billion in 2024 and is forecasted to expand at a CAGR of 7.5% to reach US$ 98.6 billion by 2034-end.

Report Attribute	Detail
Medical Equipment Maintenance Market Size (2024E)	US$ 47.8 Billion
Forecasted Market Value (2034F)	US$ 98.6 Billion
Global Market Growth Rate (2024 to 2034)	7.5% CAGR
South Korea Market Value (2034F)	US$ 5.3 Billion
Surgical Instrument Demand Growth Rate (2024 to 2034)	8.4% CAGR
Key Companies Profiled	Canon Medical Systems Corporation; Zimmer Biomet; General Electric; Koninklijke Philips N.V.; Siemens Healthcare GmbH; Medtronic; Carestream Health; Shimadzu Corporation; Agfa-Gevaert HealthCare; Olympus Corporation; Boston Scientific Corporation; Viatronix, Inc.; Terarecon, Inc.; Agenor Mantenimientos; Hoya Corporation; Smith+Nephew; Richard Wolf GmbH; KARL STORZ.

Country-wise Analysis

Attribute	United States
Market Value (2024E)	US$ 5.1 Billion
Growth Rate (2024 to 2034)	7.9% CAGR
Projected Value (2034F)	US$ 10.9 Billion

Attribute	Japan
Market Value (2024E)	US$ 3.1 Billion
Growth Rate (2024 to 2034)	8% CAGR
Projected Value (2034F)	US$ 6.7 Billion

Category-wise Analysis

Attribute	Imaging Equipment
Segment Value (2024E)	US$ 13.7 Billion
Growth Rate (2024 to 2034)	7.6% CAGR
Projected Value (2034F)	US$ 28.5 Billion

United States Mobility Aid Medical Devices Market Size, Share, Growth, Trend & US Mobility Aid Medical Devices Market Forecast 2027 By Product, By End User, By Company, By Region & Opportunities,

Pages	70
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

Medical Device Training Market Outlook

The global medical device training market size was valued at approximately USD 1.8 billion in 2023 and is projected to reach USD 3.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% over the forecast period. This significant growth is driven by the increasing complexity of medical devices, the rising adoption of advanced medical technologies, and stringent regulatory requirements necessitating comprehensive training programs for healthcare professionals.

One of the primary growth factors of the medical device training market is the rapid technological advancements in the medical device industry. As new and more complex devices are introduced to the market, there arises a critical need for healthcare professionals to be adequately trained in their use to ensure patient safety and device efficacy. This technological evolution includes the advent of AI-driven diagnostic tools, robotic surgery equipment, and personalized medical devices, all of which require specialized training modules.

Another significant driver is the rigorous regulatory landscape governing medical devices. Regulatory bodies like the FDA in the United States and the European Medicines Agency (EMA) in Europe have stringent requirements for the proper usage and handling of medical devices. Compliance with these regulations often mandates formal training programs for healthcare providers, driving demand in the medical device training market. Additionally, the increasing focus on reducing medical errors and enhancing patient outcomes further underscores the importance of comprehensive training programs.

The growing prevalence of chronic diseases and the rising geriatric population are also contributing to the market's expansion. With an increasing number of patients requiring advanced diagnostic and therapeutic devices, there is a parallel need for healthcare professionals trained in using these devices. Training programs not only ensure that devices are used correctly but also optimize their therapeutic benefits, thereby improving patient care standards. This growing demand for trained professionals is a crucial factor bolstering the market growth.

Regionally, North America holds the largest share of the medical device training market, attributed to the high adoption rate of advanced medical technologies, stringent regulatory requirements, and a well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as increasing healthcare expenditure, growing awareness about advanced medical devices, and expanding healthcare infrastructure in emerging economies like China and India are driving this regional growth. Europe and Latin America are also significant markets, driven by similar factors of technological adoption and regulatory compliance.

Training Type Analysis

The medical device training market is segmented by training type into Instructor-Led Training, Online Training, Simulation-Based Training, and Others. Instructor-Led Training remains a predominant segment due to its effectiveness in providing hands-on experience and immediate feedback to the trainees. This type of training is particularly beneficial for complex surgical devices and procedures where real-time interaction with an instructor is crucial. Moreover, the ability to customize training programs to address specific needs of different medical devices further enhances the value of instructor-led sessions.

Online Training is gaining substantial traction, driven by the increasing adoption of digital learning platforms and the need for flexible training solutions. Online modules offer the convenience of self-paced learning, making it easier for healthcare professionals to integrate training into their busy schedules. The COVID-19 pandemic has further accelerated the shift towards online training, as it provides a safe and accessible alternative to in-person sessions. The scalability of online training also makes it a cost-effective solution for institutions looking to train large numbers of staff.

Simulation-Based Training is another segment witnessing robust growth. This type of training employs advanced technologies such as virtual reality (VR) and augmented reality (AR) to create realistic scenarios for hands-on practice. Simulation-based training is particularly effective for high-risk procedures, as it allows trainees to gain experience without the risk of harming actual patients. The increasing adoption of sophisticated medical

Over the last two observations, the average revenue per user is forecast to significantly increase in all segments. However, it is evident that the growth of all two segments decelerates during the later stages of the forecast period. Specifically, the segment Digital Fitness & Well-Being shows the smallest increase at 2029, with a value of *** U.S. dollars. Find further statistics on other topics such as a comparison of the average revenue per user in the United States and a comparison of the average revenue per user in Luxembourg. The Statista Market Insights cover a broad range of additional markets.

The North American medical device reprocessing market is valued at approximately XX million in 2023 and is projected to reach over XX million by 2033, expanding at a CAGR of approximately 5.50% during the forecast period. Factors driving the growth of the market include the increasing demand for reprocessing services due to the rising healthcare costs, stringent regulatory compliance, and environmental concerns. Additionally, technological advancements and innovations in reprocessing techniques further contribute to market growth. Market segmentation by device type includes Class I and Class II devices, with Class II devices holding a major market share. Geographically, the United States holds the dominant position in the North American market, followed by Canada and Mexico. Key players in the market include Vanguar, Sterilmed Inc (Johnson & Johnson), ReNu Medical (Arjo), NEScientific, Stryker Corporation, Hygia, SureTek Medical, and Medline Industries Inc. These companies are actively involved in research and development to enhance their product offerings and strengthen their market positions. Key drivers for this market are: , Cost Savings Through Reprocessing Single-use Devices; Regulatory Pressure to Reduce Volume of Medical Waste. Potential restraints include: , Potential of Material Alteration and Cross Infection with Reprocessed Device; Preconceived Notions Regarding the Quality of Reprocessed Single-use Medical Devices (SUDs). Notable trends are: Sequential Compression Sleeves by Class II Device Segment is Poised to Register Robust Growth.

The Report Covers North America Medical Device Reprocessing Companies and the market is segmented by Device (Class I Devices, Class II Devices) and Geography.